Our Board Members
Haishan Jang, Ph. D., MBA
BRIM Taiwan Chairman, Chief Executive Officer
Haishan has over 27 years of extensive experience in the pharmaceutical industry, including at Centocor, DuPont, and Sanofi.She directed the scientific system, process and project management in biologic Clinical Pharmacology at Centocor, with responsibilities ranging across process integration/optimization for non-clinical, clinical pharmacology, pharmacokinetics, immune response, and clinical research activities. Haishan has made contributions to the development of a few brand-name drugs such as Uroxatral®, Tirazon®, Remicade®, Simponi® and Stelara®. Prior to the formation of BRIM Biotechnology, Inc., Haishan held positions of President at TWI Biotechnology and COO of the Supra Incubation and Integration Center (Si2C), a Taiwan government sponsored incubation center
Frank Lee, Ph. D.
BRIM Cayman Chairman
Frank has a total of more than 38 years of industrial experience associated with drug discovery/preclinical /clinical developments. He has made contributions to the development of brand-name drugs such as Naprosyn®, Anaprox®, Ticlid®, Torado®, Avodart®, Flonase®, Imitrex®, Zofran®, Sustiva® and Velcade®. He retired from Takeda as VP of DMPK, spent time at Millennium and DuPont, and also serves as the Chairman of BRIM Cayman.
Top Taiwan Venture Capital Group
Top Taiwan Venture Capital Group (TTVC) is the largest and leading venture capital management team based in Taiwan with a fund size around $400M USD. Across their 15 years of experience, TTVC has invested in more than 250 successful companies, many of which have later become TTVC’s investors and shareholders. The TTVC team is comprised of professionals with an average of more than 5 years of industry experience. An average of over 1000 companies a year are reviewed and new investments are continuously added to TTVC’s growing portfolio, which now covers industries such as technology, biotech, renewable energy, retail, consumer durables, healthcare, and auto parts.
Yuanta Financial Holdings
Yuanta Financial Holdings is a full-service finanical institute with dominances in securities trading and investment banking businesses. Yuanta Financial Holdings emerged from a merger in 2007 between Fuhwa Financial Holding Company and Yuanta Core Pacific Securities, which was the largest securities broker for more than a decade in Taiwan. Yuanta retains the leadership in Securities related businesses in Taiwan, and offers a wide range of services including Commercial & Merchant Banking, Life & Property Insurance, Equity Research, and Investment & Asset Management, through its subsidiaries. Yuanta has extended its reach into Asia Pacific, with operations in Hong Kong, South Korea, and South East Asia countries to enhance the firm’s capability under globalization. In the future, Yuanta Financial Holdings will continue to grow its competitiveness in securities business and to achieve one of the best financial institutes in Asia, in order to provide its clients the best in class experience.
BioEngine Capital Inc.